About Bertin Bioreagent
Founded within the Bertin group, Bertin Bioreagent develops assay kits, antibodies and bioanalytical tools for biomarker research and drug development. Its expertise focuses on the detection and measurement of biological markers involved in physiology and disease. The company provides technologies for protein quantification, enzyme activity analysis, immunoassays and cell-based assays. Its products support biomarker discovery, translational research and preclinical studies across neuroscience, endocrinology, metabolism, inflammation, immunology, toxicology and cardiovascular research. Researchers use these tools to investigate molecular pathways, evaluate therapeutic responses and characterise disease mechanisms.
Bertin Bioreagent offers a portfolio of ELISA and EIA kits, enzymatic assays, monoclonal and polyclonal antibodies, biochemical reagents and sample preparation products. The range includes assays based on immunodetection, fluorescence, chemiluminescence, reporter systems, LC-MS/MS workflows and high-throughput screening technologies. The company also supplies specialised products for lipid research, oxidative stress, nitric oxide biology, epigenetics and prion research, alongside custom assay development capabilities. These tools support workflows including biomarker quantification, protein analysis, tissue dissociation, sample preparation and cellular pathway investigation.
Europa Biosite’s subsidiaries distribute for Bertin Bioreagent in Austria and Germany.